Fidelity Adv Biotech Inst's ticker is and the CUSIP is 315918466. A total of 1 filers reported holding Fidelity Adv Biotech Inst in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $729,000 | +7.0% | 26,692 | 0.0% | 0.49% | -3.9% |
| Q3 2022 | $681,000 | +9.1% | 26,692 | 0.0% | 0.51% | +11.3% |
| Q2 2022 | $624,000 | -13.8% | 26,692 | 0.0% | 0.46% | +8.3% |
| Q1 2022 | $724,000 | -8.4% | 26,692 | 0.0% | 0.42% | -1.6% |
| Q4 2021 | $790,000 | -2.8% | 26,692 | +18.6% | 0.43% | -7.5% |
| Q3 2021 | $813,000 | +1.2% | 22,514 | +0.4% | 0.47% | +1.3% |
| Q2 2021 | $803,000 | +1.9% | 22,430 | 0.0% | 0.46% | -5.3% |
| Q1 2021 | $788,000 | -3.5% | 22,430 | 0.0% | 0.49% | -9.5% |
| Q4 2020 | $817,000 | +15.1% | 22,430 | +7.9% | 0.54% | +4.9% |
| Q3 2020 | $710,000 | -0.4% | 20,784 | 0.0% | 0.51% | -5.2% |
| Q2 2020 | $713,000 | +30.3% | 20,784 | 0.0% | 0.54% | +20.8% |
| Q1 2020 | $547,000 | -11.2% | 20,784 | 0.0% | 0.45% | +26.6% |
| Q4 2019 | $616,000 | +22.2% | 20,784 | +6.4% | 0.35% | -4.3% |
| Q3 2019 | $504,000 | -8.4% | 19,529 | 0.0% | 0.37% | -7.1% |
| Q2 2019 | $550,000 | -1.6% | 19,529 | 0.0% | 0.40% | -1.5% |
| Q1 2019 | $559,000 | +14.3% | 19,529 | 0.0% | 0.40% | +2.5% |
| Q4 2018 | $489,000 | – | 19,529 | – | 0.39% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| 1776 Wealth LLC | 9,044 | $233,336 | 0.12% |